TNFRSF9 and neoplasm: Some studies reported that the CD137 and OX40 were also expressed on the dendritic cells (DCs), which can bind to their agonistic antibodies, thereby enhancing the ability of DCs to stimulate T-cell proliferation and generate tumor antigen-specific CD8+ T-cell responses45,46.